Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System.

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Abstract Text:

E Steliarova-Foucher,V Arndt,D M Parkin,F Berrino,H Brenner,E Steliarova-Foucher,V Arndt,D M Parkin,F Berrino,H Brenner,

BACKGROUND: A few years ago, a new method of survival analysis, denoted 'period' analysis, was introduced to provide more up-to-date survival estimates of cancer patients. PATIENTS AND METHODS: We evaluated the period survival method using the large database of the Automated Childhood Cancer Information System (ACCIS). Our evaluation is based on data from 35 191 children diagnosed with cancer in 13 European countries between 1975 and 1989 and followed for vital status until around 1999. RESULTS: Using the follow-up data available in 1989, 10-year survival for all children with cancer calculated by the period method for the 1985-89 period was 58%, while it was 43% when calculated by traditional 'cohort' life-table analysis (based on children diagnosed in 1975-79). The period method provided a better estimate of the true 10-year survival of 62%, observed 10 years later in the cohort of patients diagnosed in 1985-89. Similar results were observed for each of the common groups of childhood cancer. CONCLUSION: Period analysis is especially useful for monitoring childhood cancer survival, because at a given point in time it provides more timely estimates of long-term survival expectations than the cohort life-table method. Using the ACCIS database, up-to-date estimates of period survival for childhood cancer are derived in subsequent papers in this journal.

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Publishing Authors By Initials

E Steliarova-Foucher,V Arndt,DM Parkin,F Berrino,H Brenner,E Steliarova-Foucher,V Arndt,DM Parkin,F Berrino,H Brenner,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Annals of oncology : official journal of the Europ

VOLUME: 18

Page Numbers: 1554-60

Journal Abbreviation: Ann. Oncol.

ISSN: 0923-7534

DAY: 13

MONTH: 08

YEAR: 2007

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9007735

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System.

AFFILIATION: Data Analysis and Interpretation Group, International Agency for Research on Cancer, Lyon, France. steliarova@iarc.fr

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ann Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System Related Publications

• Adolescents as victims of familial violence: a hospital based surveillance.
• An S6 mutation in BK channels reveals beta1 subunit effects on intrinsic and voltage-dependent gating.
• Antiprogestin-releasing intrauterine devices: a novel approach to endometrial contraception.
• BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells.
• Cadherin-11 in synovial lining formation and pathology in arthritis.
• Cost-saving analysis of screening colonoscopy in Germany.
• Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes.
• Effect of insulin on the oxidative desaturation ofa-linolenic, oleic and palmitic acids.
• Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany.
• Fifth Annual ISHAGE Meeting - Oslo 1999.
• Haptic search with finger movements: using more fingers does not necessarily reduce search times.
• Losartan in patients with type 2 diabetes and proteinuria: Observations from the RENAAL Study.
• Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+.
• Non-invasive in vivo diffuse optical spectroscopy monitoring of cyanide poisoning in a rabbit model.
• Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.
• Protein molecular function prediction by Bayesian phylogenomics.
• Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.
• Relation between neural response telemetry thresholds, T- and C-levels, and loudness judgments in 12 adult nucleus 24 cochlear implant recipients.
• Relative incorporation of linoleic and arachidonic acid in phospholipids and triglycerides of different rat tissues.
• Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links.
• Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
• Testing the stand-alone microbeam at Columbia University.
• The continuing contribution of gene marking to cell and gene therapy.
• The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells.
• The more eyes, the better to see? From double to quadruple reading of screening mammograms.
• The phosphatidyl ethanolamine ofPseudomonas aeruginosa grown in hexadecane.
• Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System.
• Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?
• Update on the pfam5000 strategy for selection of structural genomics targets.
• Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts.